NewsBenzingaFDA's Office Of Prescription Drug Promotion Reviews Amgen's Submitted Video For VECTIBIX Injection For Intravenous Use; FDA Determines Video Is False Or Misleading And Breaches Federal Food, Drug, And Cosmetic Act FDA's Office Of Prescription Drug Promotion Reviews Amgen's Submitted Video For VECTIBIX Injection For Intravenous Use; FDA Determines Video Is False Or Misleading And Breaches Federal Food, Drug, And Cosmetic Act Benzinga 2026.10.27 17:45 (GMT+0) Open on Benzinga Other news If You Invested $100 In BBVA Stock 5 Years Ago, You Would Have This Much Today China Pharma Holding Q3 EPS $(0.04) Up From $(0.17) YoY, Sales $1.153M Up From $756.217K YoY New Jersey Resources Sees FY2027 Adj EPS $3.25-$3.40 vs $3.45 Est Helmerich & Payne Q4 Adj. EPS $0.36 Beats $0.27 Estimate, Sales $1.092B Beat $1.073B Estimate Bitwise Moves Beyond Crypto With AI Cyber Defense ETF NEAR Says Take-Two–Linked Token Is Live on Near.com